Conferences

A study presented at TCT 2018 questioned the benefits of “drip-and-ship” for elderly patients with ST-segment elevation myocardial infarction (STEMI), finding patients in their 80s or older who were transferred with fibrinolytic therapy for PCI had an eight-fold risk of hemorrhagic stroke but no survival advantage.
Thumbnail
Lorcaserin, an appetite suppressant approved for chronic weight management in 2012, reduced…
Thumbnail
With CMS set to release a new National Coverage Determination (NCD) for transcatheter aortic valve…
Thumbnail
Some cardiologists at TCT 2018 worried negative posts about ongoing trials could affect patient…
Thumbnail
A press conference at the 2018 Transcatheter Cardiovascular Therapeutics meeting in San Diego on…
Thumbnail
Acute coronary syndrome patients who were given a loading dose of atorvastatin before percutaneous…
Thumbnail
With additional testing for nonobstructive coronary artery disease (CAD), researchers effectively…